| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |